Own 500 Pfizer and JNJ Shares: Here’s Your Dividend Income
Healthcare megacaps Pfizer and Johnson & Johnson continue to deliver quarterly dividends that can generate reliable i...
Learn when to do a Backdoor Roth in 2026, including optimal timing around income, limits, and market conditions.
15,255 articlesHealthcare megacaps Pfizer and Johnson & Johnson continue to deliver quarterly dividends that can generate reliable i...
Pfizer is quietly building a GLP-1 obesity pipeline that could alter the competitive landscape, while investors seek ...
A leading cybersecurity stock surged about 62% in 2026, propelled by artificial intelligence (ai) innovations. This a...
Job seekers are facing increasingly convincing thieves using AI to mimic recruiters and fake interview portals. Exper...
U.S. regulators have begun a CIP-based compliance clock for stablecoin issuers, tying direct customer onboarding to f...
AI funding is surging in 2026, signaling a new investment wave. Here's how an investor ahead next investment can posi...
A late-life mortgage decision that looked smart on math may falter when survivorship risk hits the household budget. ...
AMD's quarterly results show data-center strength lifting the growth story. This piece maps a 5-year prediction stock...
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
AI-driven demand for high-bandwidth memory is squeezing the global supply, raising costs for devices and testing Appl...
IWM holders confront higher annual fees and a recurring reconstitution drag that can erode returns. Cheaper small-cap...
As Verizon nears its July 24 earnings, investors are eyeing a potential near-25% upside driven by steady cash flow, a...